Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03574181 · ClinicalTrials.gov registry record
Calibration Study of a Blood Alcohol Level Smart Watch
A clinical trial, sponsored by Boston Medical Center.
- Terminated
- Registry status
- 9
- Enrollment target
NCT03574181 is a clinical trial that was terminated before completion, run by Boston Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT03574181 was terminated before completion, sponsored by Boston Medical Center.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This trial is designed to test the accuracy of a wristwatch blood alcohol level monitor relative to alcohol breath testing. An established human laboratory self-administration procedure will be followed. Each subject will complete 2 clinic visits over a period of up to 21 days of participation. Study participation is comprised of a baseline assessment to determine eligibility and an alcohol self-administration trial to test the accuracy of the wrist watch blood alcohol level. Subjects will be recruited in two phases of 9 subjects each. The first phase will be conducted to validate a prototype of the wrist watch. The second phase will be conducted to validate a pre-production consumer model of the blood alcohol wrist watch.
Interventions
- OTHER Smartwatch to measure Blood Alcohol Level (BAL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-07-08 |
| Est. Completion | 2020-02-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03574181
The ClinicalTrials.gov registry entry for NCT03574181 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smartwatch to measure Blood Alcohol Level (BAL) is the first listed.
NCT03574181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03574181 about?
NCT03574181 is a clinical study titled "Calibration Study of a Blood Alcohol Level Smart Watch". This trial is designed to test the accuracy of a wristwatch blood alcohol level monitor relative to alcohol breath testing. An established human laboratory self-administration procedure will be followed. Each subject will complete 2 clinic visits over a period of up to 21 days of participation. Stud...
What is the current status of trial NCT03574181?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2019-07-08. Estimated completion is 2020-02-17.
What interventions are being tested in trial NCT03574181?
The interventions under investigation include: Smartwatch to measure Blood Alcohol Level (BAL) (OTHER).
Who is sponsoring clinical trial NCT03574181?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.